Synthetic opioids

In this Thursday, Dec. 19, 2019 photo, pedestrians pass at St. Luke's Cornwall Hospital in Newburgh, N.Y. The hospital adopted the Hudson Valley Interlink Analytic System earlier this year, which tracks drug overdoses in New York. The system is among a number of surveillance systems being adopted around the country by police, government agencies and community groups. (AP Photo/Frank Franklin II)
December 23, 2019 - 7:37 am
ALBANY, N.Y. (AP) — Drug overdose patients rushed to some emergency rooms in New York's Hudson Valley are asked a series of questions: Do you have stable housing? Do you have food? Times and location of overdoses are noted, too. The information is entered into a new overdose-tracking system that...
Read More
CORRECTS TO CAPITAL, NOT CAPITOL- In this Nov. 14, 2019 photo, Jamie Cline poses for a photo behind a glass window in a door at the Olympia Bupe Clinic at the Capital Recovery Center in Olympia, Wash., which helps people addicted to heroin and other opiates get prescriptions for buprenorphine, a medicine that prevents withdrawal sickness in people trying to stop using opiates. At the clinic, a doctor is working to spread a philosophy called "medication first," which scraps requirements for counseling, abstinence or even a commitment to recovery in the battle against opioid addiction. (AP Photo/Ted S. Warren)
December 18, 2019 - 2:50 pm
OLYMPIA, Wash. (AP) — Every time she got out of jail, Jamie Cline started hustling again for heroin, driven by an addiction she didn’t understand. “You want to get clean so bad. You know something’s killing you and you can’t stop,” said the 33-year-old who used heroin for 10 years. This spring was...
Read More
CORRECTS TO CAPITAL, NOT CAPITOL- In this Nov. 14, 2019 photo, Jamie Cline poses for a photo behind a glass window in a door at the Olympia Bupe Clinic at the Capital Recovery Center in Olympia, Wash., which helps people addicted to heroin and other opiates get prescriptions for buprenorphine, a medicine that prevents withdrawal sickness in people trying to stop using opiates. At the clinic, a doctor is working to spread a philosophy called "medication first," which scraps requirements for counseling, abstinence or even a commitment to recovery in the battle against opioid addiction. (AP Photo/Ted S. Warren)
December 18, 2019 - 2:36 pm
OLYMPIA, Wash. (AP) — Every time she got out of jail, Jamie Cline started hustling again for heroin, driven by an addiction she didn’t understand. “You want to get clean so bad. You know something’s killing you and you can’t stop,” said the 33-year-old who used heroin for 10 years. This spring was...
Read More
CORRECTS TO CAPITAL, NOT CAPITOL- In this Nov. 14, 2019 photo, Jamie Cline poses for a photo behind a glass window in a door at the Olympia Bupe Clinic at the Capital Recovery Center in Olympia, Wash., which helps people addicted to heroin and other opiates get prescriptions for buprenorphine, a medicine that prevents withdrawal sickness in people trying to stop using opiates. At the clinic, a doctor is working to spread a philosophy called "medication first," which scraps requirements for counseling, abstinence or even a commitment to recovery in the battle against opioid addiction. (AP Photo/Ted S. Warren)
December 18, 2019 - 1:57 pm
Read More
FILE - This undated file photo provided by the U.S. Attorneys Office for Utah and introduced as evidence at a trial shows fentanyl-laced fake oxycodone pills collected during an investigation. Accidental overdoses contribute to 90 percent of all U.S. opioid-related deaths. Rising use of illicitly manufactured and highly potent synthetic opioids including fentanyl has likely contributed to the unintentional death rate, which surged nine-fold between 2000 and 2017, the study found. (U.S. Attorneys Office for Utah via AP, File)
December 17, 2019 - 1:05 pm
Accidental overdoses cause 90% of all U.S. opioid-related deaths while suicides account for far fewer of these fatalities than previously thought, a new analysis published Tuesday suggests. Rising use of heroin and illicit, highly potent synthetic opioids including fentanyl has likely contributed...
Read More
FILE - In this Thursday, Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. A new court filing shows that the wealthy owners of OxyContin maker Purdue Pharma started taking far more money out of the company after it was fined in 2007 for misleading marketing of the powerful prescription painkiller. (AP Photo/Frank Franklin II, File)
December 16, 2019 - 10:24 pm
The wealthy owners of OxyContin maker Purdue Pharma started taking far more money out of the company after it was fined for misleading marketing of the powerful prescription painkiller. A court filing made by the company Monday evening shows Purdue made payments for the benefit of members of the...
Read More
FILE - In this Thursday, Sept. 12, 2019, file photo, cars pass Purdue Pharma headquarters in Stamford, Conn. A new court filing shows that the wealthy owners of OxyContin maker Purdue Pharma started taking far more money out of the company after it was fined in 2007 for misleading marketing of the powerful prescription painkiller. (AP Photo/Frank Franklin II, File)
December 16, 2019 - 9:22 pm
The wealthy owners of OxyContin maker Purdue Pharma started taking far more money out of the company after it was fined for misleading marketing of the powerful prescription painkiller. A court filing made by the company Monday evening shows Purdue made payments for the benefit of members of the...
Read More
December 16, 2019 - 8:51 pm
The wealthy owners of OxyContin maker Purdue Pharma started taking far more money out of the company after it was fined for misleading marketing of the powerful prescription painkiller. A court filing made by the company Monday evening shows Purdue made payments for the benefit of members of the...
Read More
This Dec. 12, 2019, photo shows a sign at the Mundipharma International headquarters at Cambridge Science Park in England. Mundipharma is the international affiliate of Purdue Pharma, the maker of the blockbuster painkiller OxyContin. Mundipharma is now marketing Nyxoid, a new brand of naloxone, an opioid overdose reversal medication. (AP Photo/Leila Coker)
December 15, 2019 - 10:06 pm
The gleaming white booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on its walls said. Some conference attendees were stunned when they saw the company logo: Mundipharma, the...
Read More
This Dec. 12, 2019, photo shows a sign at the Mundipharma International headquarters at Cambridge Science Park in England. Mundipharma is the international affiliate of Purdue Pharma, the maker of the blockbuster painkiller OxyContin. Mundipharma is now marketing Nyxoid, a new brand of naloxone, an opioid overdose reversal medication. (AP Photo/Leila Coker)
December 15, 2019 - 3:22 pm
The gleaming white booth towered over the medical conference in Italy in October, advertising a new brand of antidote for opioid overdoses. “Be prepared. Get naloxone. Save a life,” the slogan on its walls said. Some conference attendees were stunned when they saw the company logo: Mundipharma, the...
Read More

Pages